相关实验视频
Updated: Jun 14, 2026

06:17
Expression and Purification of Virus-like Particles for Vaccination
Published on: June 2, 2016
22.7K
下一代菲洛病毒疫苗的合理设计,将糖蛋白稳定和纳米粒子显示与糖修饰结合起来
Yi-Zong Lee1, Yi-Nan Zhang1, Maddy L Newby2
1Department of Integrative Structural and Computational Biology, The Scripps Research Institute, La Jolla, CA, USA.
Nature communications
|December 12, 2025
概括
开发一种广泛保护的菲洛病毒疫苗至关重要. 这项研究使用纳米粒子稳定了filovirus糖蛋白 (GP),增强了免疫反应,并为下一代针对埃博拉等致命病毒的疫苗提供了基础.
科学领域:
- 病毒学 病毒学
- 免疫学 免疫学 免疫学
- 疫苗开发 疫苗开发
背景情况:
- 菲洛病毒,包括埃博拉病毒和马尔堡病毒,导致频繁,高死亡率的疫情.
- 现有的埃博拉病毒疫苗是以载体为基础的,但仍然需要一种广泛保护的菲洛病毒疫苗.
研究的目的:
- 评估一项用于稳定多个orthoebolavirus和orthomarburgvirus中的filovirus糖蛋白 (GP) 的一般策略.
- 研究自我组装蛋白质纳米粒子 (SApNPs) 的潜力,以显示稳定的GP并提高疫苗的疗效.
主要方法:
- 来自埃博拉病毒,苏丹病毒,Bundibugyo病毒和Ravn病毒的葡萄糖蛋白 (GP) 的稳定.
- 使用X射线结晶学和冷电子显微镜进行结构分析.
- 提供GP的SApNP的发展和特征 (I3-01v9).
- 在小鼠体内研究以评估淋巴结动态和免疫反应.
主要成果:
- 稳定埃博拉病毒GP的原子层结构细节和苏丹病毒GP的保留抗体结合点.
- 与可溶性trimers相比,SApNPs在淋巴结毛囊中的保留和树突细胞上的呈现显著增强.
- SApNP诱导了更强的生殖中心反应和功能性抗体反应.
结论:
- 在SApNP上显示的稳定型菲洛病毒GP为下一代菲洛病毒疫苗提供了一个有希望的平台.
- 这种方法增强了抗原呈现,并促进了强大的免疫反应.
- 这些发现为开发针对细菌病毒的广泛保护性疫苗提供了基础.
更多相关视频
10:58Production of E. coli-expressed Self-Assembling Protein Nanoparticles for Vaccines Requiring Trimeric Epitope Presentation
Published on: August 21, 2019
7.9K
08:07A "Plug-And-Display" Nanoparticle Vaccine Platform Based on Outer Membrane Vesicles Displaying SARS-CoV-2 Receptor-Binding Domain
Published on: July 25, 2022
3.0K
相关概念视频
Vaccine Production
Vaccine production involves a sequence of upstream and downstream processes to generate a safe and effective immunological product. It begins with cultivating microorganisms, such as viruses or bacteria, to obtain antigenic material. For viral vaccines, mammalian host cells are grown in bioreactors and subsequently infected with the target virus. The virus replicates within the host cells, which are lysed to release viral particles. This lysate is then clarified through filtration or...
Inhibitors Of Virion Release
Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...